Figure 6

Effects of the PPARδ-agonist on adipogenic marker expression in adipose tissue in 2K1C animals—treated with and without GW 501516 or GW 501516+SnMP. (a–d) Western blot and densitometry analysis of mest, C/EBPα, Wnt5b and fatty acid synthase (FAS) levels, respectively; *P<0.05 vs control, #P<0.05 vs 2K1C,+P<0.05 vs 2K1C+GW. Results are means±s.e., n=6/group; data are shown as mean band density normalized to β-actin.